Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vel/Dex Induction and Molecular Remission in Multiple Myeloma
NCT00861250Phase 3Completed
- Sponsor
- Tampere University Hospital
- Start
- Mar 2009
- Primary completion
- Dec 2014
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of bortezomib in multiple myeloma (MM), sponsored by Tampere University Hospital. Started Mar 2009; status: completed.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00861250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861250.